UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Cardiovascular research, 2003-04, Vol.58 (1), p.32-45

2003

Volltextzugriff (PDF)

Evaluation of drug-induced QT interval prolongation : Implications for drug approval and labelling

Drug safety, 2001, Vol.24 (5), p.323-351

2001

Volltextzugriff (PDF)

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

The Lancet (British edition), 1997-03, Vol.349 (9053), p.667-674

1997

Volltextzugriff (PDF)

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

The Lancet (British edition), 2000-05, Vol.355 (9215), p.1582-1587

2000

Volltextzugriff (PDF)

State of play and future direction with NOACs: An expert consensus

Vascular pharmacology, 2018-07, Vol.106, p.9-21

2018

Volltextzugriff (PDF)

Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction

The Lancet (British edition), 1999-04, Vol.353 (9162), p.1390-1396

1999

Volltextzugriff (PDF)

Early management of atrial fibrillation to prevent cardiovascular complications

European heart journal, 2014-06, Vol.35 (22), p.1448-1456

2014

Volltextzugriff (PDF)

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion

Europace (London, England), 2014-05, Vol.16 (5), p.626-630

2014

Volltextzugriff (PDF)

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Europace (London, England), 2011-03, Vol.13 (3), p.308-328

2011

Volltextzugriff (PDF)

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Cardiovascular research, 2000-08, Vol.47 (2), p.219-233

2000

Volltextzugriff (PDF)

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Circulation (New York, N.Y.), 1997-07, Vol.96 (2), p.404-407

1997

Volltextzugriff (PDF)

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Europace (London, England), 2011-05, Vol.13 (5), p.610-625

2011

Volltextzugriff (PDF)

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

European heart journal, 2015-09, Vol.36 (33), p.2239-2245

2015

Volltextzugriff (PDF)

Heart rate variability : Standards of measurement, physiological interpretation, and clinical use

European heart journal, 1996-03, Vol.17 (3), p.354-381

1996

Volltextzugriff (PDF)

Clinical relevance of silent atrial fibrillation : Prevalence, prognosis, quality of life, and management

Journal of interventional cardiac electrophysiology, 2000-06, Vol.4 (2), p.369-382

2000

Volltextzugriff (PDF)

Atrial fibrillation in the military patient: a review

Journal of the Royal Army Medical Corps, 2015-09, Vol.161 (3), p.237-243

2015

Volltextzugriff (PDF)

Congenital and acquired long QT syndrome

European heart journal, 2000-08, Vol.21 (15), p.1232-1237

2000

Volltextzugriff (PDF)

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

European heart journal, 2000-08, Vol.21 (15), p.1216-1231

2000

Volltextzugriff (PDF)

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

Cardiovascular research, 2001-03, Vol.49 (4), p.741-750

2001

Volltextzugriff (PDF)

The Utilization of the Implantable Defibrillator—a European Enigma

European heart journal, 2000-12, Vol.21 (24), p.1998-2004

2000

Volltextzugriff (PDF)

Atrial fibrillation: current knowledge and recommendations for management

European heart journal, 1998-09, Vol.19 (9), p.1294-1320

1998

Volltextzugriff (PDF)

Atrial fibrillation: the rate versus rhythm management controversy

The Journal of the Royal College of Physicians of Edinburgh, 2012, Vol.42 Suppl 18 (Suppl 18), p.23-34

2012

Volltextzugriff (PDF)

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Europace (London, England), 2010-10, Vol.12 (10), p.1480-1489

2010

Volltextzugriff (PDF)

Atrioverter : An implantable device for the treatment of atrial fibrillation

Circulation (New York, N.Y.), 1998-10, Vol.98 (16), p.1651-1656

1998

Volltextzugriff (PDF)

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin

European heart journal, 2009-11, Vol.30 (21), p.2554-2555

Camm, A. John

2009

Volltextzugriff (PDF)

1 – 25 von 2.039

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieHeart

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.512)
Mit Volltextzugriff
(1.655)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.064)
Life Sciences & Biomedicine
(991)
Humans
(980)
Cardiovascular System & Cardiology
(709)
Cardiac & Cardiovascular Systems
(693)
Male
(480)
Female
(477)
Biological And Medical Sciences
(415)
Middle Aged
(395)
Medical Sciences
(389)
Aged
(297)
Adult
(284)
Electrocardiography
(271)
Heart
(230)
Cardiology. Vascular System
(211)
Technology
(207)
Engineering
(186)
Atrial Fibrillation
(183)
Risk Factors
(160)
Engineering, Biomedical
(152)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid
(1.061)
MEDLINE
(1.030)
Ingenta.com
(876)
Free E-Journal (出版社公開部分のみ）
(818)
Elsevier ScienceDirect Journals Complete
(391)
Oxford Journals
(363)
Wiley Online Library All Journals
(354)
Oxford Journals 2020 Medicine
(344)
Ebook Central Perpetual and DDA
(295)
NUS Single-Journal Subscriptions
(294)
eBooks on EBSCOhost
(293)
Elsevier ScienceDirect Journals Complete
(278)
Wiley Online Library Full Collection 2018
(265)
IngentaConnect Journals
(183)
Wiley Online Library All Obooks
(183)
EBSCOhost Business Source Ultimate
(71)
BMJ_英国医学会期刊
(63)
SpringerLink_现刊
(59)
JSTOR
(57)
Psychology & Behavioral Sciences Collection
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Heart Journal
(196)
Pacing And Clinical Electrophysiology
(149)
Europace
(104)
The American Journal Of Cardiology
(89)
Journal Of The American College Of Cardiology
(80)
Clinical Cardiology
(63)
Circulation
(62)
Clinical Science
(53)
The Lancet
(53)
The American Heart Journal
(40)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Evaluation of drug-induced QT interval prolongation : Implications for drug approval and labelling

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

State of play and future direction with NOACs: An expert consensus

Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction

Early management of atrial fibrillation to prevent cardiovascular complications

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

Heart rate variability : Standards of measurement, physiological interpretation, and clinical use

Clinical relevance of silent atrial fibrillation : Prevalence, prognosis, quality of life, and management

Atrial fibrillation in the military patient: a review

Congenital and acquired long QT syndrome

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

The Utilization of the Implantable Defibrillator—a European Enigma

Atrial fibrillation: current knowledge and recommendations for management

Atrial fibrillation: the rate versus rhythm management controversy

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Atrioverter : An implantable device for the treatment of atrial fibrillation

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin

Aktive Filter

Suchergebnisse filtern